PandaOmics: An AI-Driven Platform for Therapeutic Target and Biomarker Discovery
Petrina Kamya, Alex Zhavoronkov(Hong Kong Science and Technology Parks Corporation), Sha Lin(Xiangyang Central Hospital), Xi Long(Hong Kong Science and Technology Parks Corporation), Kyle Tretina(Hong Kong Science and Technology Parks Corporation), Daniil Polykovskiy(Hong Kong Science and Technology Parks Corporation), Ivan V. Ozerov(Hong Kong Science and Technology Parks Corporation), Mikhail Korzinkin(Insilico Medicine (United States)), Tatyana Fokina(Hong Kong Science and Technology Parks Corporation), Shan Chen, Feng Ren(Unknown), Vladimir Naumov(Hong Kong Science and Technology Parks Corporation), Alex Aliper(Hong Kong Science and Technology Parks Corporation), Frank W. Pun(Hong Kong Science and Technology Parks Corporation)
Cited by 125
Related Papers
Deep biomarkers of human aging: Application of deep neural networks to biomarker development
|Aging|2016|377
AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor
|Chemical Science|2023|322
Validation of biomarkers of aging
|Nature Medicine|2024|299
A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models
|Nature Biotechnology|2024|265
Chemistry42: An AI-Driven Platform for Molecular Design and Optimization
|Journal of Chemical Information and Modeling|2023|196